TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Nanosonics Limited ( (AU:NAN) ) has provided an update.
Nanosonics Limited has appointed William Haydon as the Regional President for North America, effective December 1, 2025, following the retirement of Ken Shaw. Haydon’s extensive experience in the medical device and healthcare technology sectors, particularly in infection prevention and endoscope reprocessing, aligns with Nanosonics’ strategic priorities as it prepares to commercialize its CORIS® platform, marking a significant step in its growth strategy.
The most recent analyst rating on (AU:NAN) stock is a Sell with a A$4.10 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited is a leader in infection prevention solutions, focusing on medical device reprocessing systems. The company is known for its innovative products like trophon® for ultrasound probe reprocessing and is preparing to launch the CORIS® platform for endoscope reprocessing.
Average Trading Volume: 687,759
Technical Sentiment Signal: Buy
Current Market Cap: A$1.31B
Find detailed analytics on NAN stock on TipRanks’ Stock Analysis page.